BDS
ONC icon

Banco de Sabadell’s BeOne Medicines Ltd ONC Stock Holding History

Banco de Sabadell’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,081
Closed -$1.03M – 300
2021
Q1 		$1.03M Buy
3,081
+330
+12% +$109K 0.11% 135
2020
Q4 		$695K Hold
2,751
– – 0.07% 174
2020
Q3 		$778K Hold
2,751
– – 0.09% 191
2020
Q2 		$519K Buy
+2,751
New +$448K 0.07% 173

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Banco de Sabadell's ONC Position: Q2 2021 in Review

Banco de Sabadell sold out of BeOne Medicines Ltd (ONC) in Q2 2021, closing a stake of 3,081 shares — an estimated $1.03M sold.

Banco de Sabadell first reported a position in ONC in Q2 2020 and held it in 4 quarters. The position peaked at $1.03M in Q1 2021. 268 funds tracked by Wall St. Rank hold ONC as of Q2 2021.

  • Banco de Sabadell reported no remaining BeOne Medicines Ltd position as of Q2 2021 after selling out during the quarter.
  • Banco de Sabadell sold 3,081 BeOne Medicines Ltd shares in Q2 2021, an estimated $1.03M.
  • Banco de Sabadell first reported a position in BeOne Medicines Ltd in Q2 2020 and held it in 4 quarters.
  • Banco de Sabadell's BeOne Medicines Ltd position peaked at $1.03M in Q1 2021.
  • 268 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2021.

Based on Banco de Sabadell's 13F filing for Q2 2021, filed 13 Aug 2021.